Mammalian Target of Rapamycin Pathway Assessment in Antiphospholipid Antibody-Positive Patients with Livedo. Sevim E, Siddique S, Chalasani MLS, Chyou S, et al. J Rheumatol 2022;49:1026-1030.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Sevim E, Siddique S, Chalasani MLS, Chyou S, et al. Mammalian Target of Rapamycin Pathway Assessment in Antiphospholipid Antibody-Positive Patients with Livedo. J Rheumatol 2022;49:1026-1030.
PMID: 35649551